Cargando…

Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System

Neuromyelitis optica (NMO) is a recurrent inflammatory disease that preferentially targets the optic nerves and spinal cord leading to blindness and paralysis. The hallmarks of NMO include bilateral optic neuritis and longitudinally extensive transverse myelitis. Woman and African Americans are over...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jiwon, Levy, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272864/
https://www.ncbi.nlm.nih.gov/pubmed/22363840
http://dx.doi.org/10.1155/2012/460825
_version_ 1782222851300917248
author Oh, Jiwon
Levy, Michael
author_facet Oh, Jiwon
Levy, Michael
author_sort Oh, Jiwon
collection PubMed
description Neuromyelitis optica (NMO) is a recurrent inflammatory disease that preferentially targets the optic nerves and spinal cord leading to blindness and paralysis. The hallmarks of NMO include bilateral optic neuritis and longitudinally extensive transverse myelitis. Woman and African Americans are overrepresented in the US patient population. NMO is associated with the NMO-IgG biomarker, which targets the aquaporin-4 water channel on astrocytes. The humoral pathology of NMO lesions include IgG and IgM deposits and infiltration by granulocytes suggesting that the NMO-IgG may be involved in the pathogenesis of disease. This review of the recent NMO literature covers the clinical features, epidemiology, radiology and pathology of disease and includes discussion of the important basic science research work in the field.
format Online
Article
Text
id pubmed-3272864
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-32728642012-02-23 Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System Oh, Jiwon Levy, Michael Neurol Res Int Review Article Neuromyelitis optica (NMO) is a recurrent inflammatory disease that preferentially targets the optic nerves and spinal cord leading to blindness and paralysis. The hallmarks of NMO include bilateral optic neuritis and longitudinally extensive transverse myelitis. Woman and African Americans are overrepresented in the US patient population. NMO is associated with the NMO-IgG biomarker, which targets the aquaporin-4 water channel on astrocytes. The humoral pathology of NMO lesions include IgG and IgM deposits and infiltration by granulocytes suggesting that the NMO-IgG may be involved in the pathogenesis of disease. This review of the recent NMO literature covers the clinical features, epidemiology, radiology and pathology of disease and includes discussion of the important basic science research work in the field. Hindawi Publishing Corporation 2012 2012-01-29 /pmc/articles/PMC3272864/ /pubmed/22363840 http://dx.doi.org/10.1155/2012/460825 Text en Copyright © 2012 J. Oh and M. Levy. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Oh, Jiwon
Levy, Michael
Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System
title Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System
title_full Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System
title_fullStr Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System
title_full_unstemmed Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System
title_short Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System
title_sort neuromyelitis optica: an antibody-mediated disorder of the central nervous system
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272864/
https://www.ncbi.nlm.nih.gov/pubmed/22363840
http://dx.doi.org/10.1155/2012/460825
work_keys_str_mv AT ohjiwon neuromyelitisopticaanantibodymediateddisorderofthecentralnervoussystem
AT levymichael neuromyelitisopticaanantibodymediateddisorderofthecentralnervoussystem